Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age

Similar articles for PMID: 2146310

Showing 1 to 12 of 112 entries
Sorted by: Best Match Show Resources per page
Dehydroepiandrosterone: the "missing link" between hyperinsulinemia and atherosclerosis?.

FASEB journal : official publication of the Federation of American Societies for Experimental Biology

Nestler JE, Clore JN, Blackard WG.
PMID: 1387859
FASEB J. 1992 Sep;6(12):3073-5. doi: 10.1096/fasebj.6.12.1387859.

A well-established epidemiologic association exists between hyperinsulinemia and macrovascular disease. However, the mechanism or mechanisms by which hyperinsulinemia promotes atherogenesis is unknown. Recent evidence indicates that the adrenal steroid dehydroepiandrosterone (DHEA) exerts multiple antiatherogenic effects and also suggests that...

Cite
Nestler JE, Clore JN, Blackard WG. Dehydroepiandrosterone: the "missing link" between hyperinsulinemia and atherosclerosis?. FASEB J. 1992;6(12):3073-5doi: 10.1096/fasebj.6.12.1387859.
Nestler, J. E., Clore, J. N., & Blackard, W. G. (1992). Dehydroepiandrosterone: the "missing link" between hyperinsulinemia and atherosclerosis?. FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 6(12), 3073-5. https://doi.org/10.1096/fasebj.6.12.1387859
Nestler, J E, et al. "Dehydroepiandrosterone: the "missing link" between hyperinsulinemia and atherosclerosis?." FASEB journal : official publication of the Federation of American Societies for Experimental Biology vol. 6,12 (1992): 3073-5. doi: https://doi.org/10.1096/fasebj.6.12.1387859
Nestler JE, Clore JN, Blackard WG. Dehydroepiandrosterone: the "missing link" between hyperinsulinemia and atherosclerosis?. FASEB J. 1992 Sep;6(12):3073-5. doi: 10.1096/fasebj.6.12.1387859. PMID: 1387859.
Copy Download .nbib Format: NLM
Dehydroepiandrosterone sulfate (DHEA-S) and DHEA-S-like compounds in fibrocystic disease of the breast.

Steroids

Chasalow FI, Blethen SL, Bradlow HL.
PMID: 2978280
Steroids. 1988 Sep;52(3):205-15. doi: 10.1016/0039-128x(88)90004-9.

We assayed Type 1 (high K+) and Type 2 (high Na+) human breast cyst fluids for DHEA-S. When an antibody specific for the 3-sulfoconjugate end of DHEA-S was used, Type 1 cyst fluids (n = 18) showed a content...

Cite
Chasalow FI, Blethen SL, Bradlow HL. Dehydroepiandrosterone sulfate (DHEA-S) and DHEA-S-like compounds in fibrocystic disease of the breast. Steroids. 1988;52(3):205-15doi: 10.1016/0039-128x(88)90004-9.
Chasalow, F. I., Blethen, S. L., & Bradlow, H. L. (1988). Dehydroepiandrosterone sulfate (DHEA-S) and DHEA-S-like compounds in fibrocystic disease of the breast. Steroids, 52(3), 205-15. https://doi.org/10.1016/0039-128x(88)90004-9
Chasalow, F I, et al. "Dehydroepiandrosterone sulfate (DHEA-S) and DHEA-S-like compounds in fibrocystic disease of the breast." Steroids vol. 52,3 (1988): 205-15. doi: https://doi.org/10.1016/0039-128x(88)90004-9
Chasalow FI, Blethen SL, Bradlow HL. Dehydroepiandrosterone sulfate (DHEA-S) and DHEA-S-like compounds in fibrocystic disease of the breast. Steroids. 1988 Sep;52(3):205-15. doi: 10.1016/0039-128x(88)90004-9. PMID: 2978280.
Copy Download .nbib Format: NLM
Elevated serum DHEA-S levels in association with hyperprolactinemia.

Endocrinologia japonica

Seki K, Kato K.
PMID: 6454571
Endocrinol Jpn. 1981 Feb;28(1):79-81. doi: 10.1507/endocrj1954.28.79.

Serum DHEA-S levels were significantly higher in women with hyperprolactinemia than in normal women during the early follicular phase. When comparison was made of serum DHEA-S levels in hyper-and normoprolactinemic patients with secondary amenorrhea due to hypothalamic-pituitary failure, serum...

Cite
Seki K, Kato K. Elevated serum DHEA-S levels in association with hyperprolactinemia. Endocrinol Jpn. 1981;28(1):79-81doi: 10.1507/endocrj1954.28.79.
Seki, K., & Kato, K. (1981). Elevated serum DHEA-S levels in association with hyperprolactinemia. Endocrinologia japonica, 28(1), 79-81. https://doi.org/10.1507/endocrj1954.28.79
Seki, K, and Kato, K. "Elevated serum DHEA-S levels in association with hyperprolactinemia." Endocrinologia japonica vol. 28,1 (1981): 79-81. doi: https://doi.org/10.1507/endocrj1954.28.79
Seki K, Kato K. Elevated serum DHEA-S levels in association with hyperprolactinemia. Endocrinol Jpn. 1981 Feb;28(1):79-81. doi: 10.1507/endocrj1954.28.79. PMID: 6454571.
Copy Download .nbib Format: NLM
Dehydroepiandrosterone sulfate, incidence of myocardial infarction, and extent of atherosclerosis in men.

Circulation

LaCroix AZ, Yano K, Reed DM.
PMID: 1423966
Circulation. 1992 Nov;86(5):1529-35. doi: 10.1161/01.cir.86.5.1529.

BACKGROUND: Antiatherogenic effects of dehydroepiandrosterone (DHEA) and dehydroepiandrosterone sulfate (DHEAS) have been suspected for more than 30 years, yet the available evidence to support or refute such effects in humans is inconclusive. The hypothesis has not been adequately tested...

Cite
LaCroix AZ, Yano K, Reed DM. Dehydroepiandrosterone sulfate, incidence of myocardial infarction, and extent of atherosclerosis in men. Circulation. 1992;86(5):1529-35doi: 10.1161/01.cir.86.5.1529.
LaCroix, A. Z., Yano, K., & Reed, D. M. (1992). Dehydroepiandrosterone sulfate, incidence of myocardial infarction, and extent of atherosclerosis in men. Circulation, 86(5), 1529-35. https://doi.org/10.1161/01.cir.86.5.1529
LaCroix, A Z, et al. "Dehydroepiandrosterone sulfate, incidence of myocardial infarction, and extent of atherosclerosis in men." Circulation vol. 86,5 (1992): 1529-35. doi: https://doi.org/10.1161/01.cir.86.5.1529
LaCroix AZ, Yano K, Reed DM. Dehydroepiandrosterone sulfate, incidence of myocardial infarction, and extent of atherosclerosis in men. Circulation. 1992 Nov;86(5):1529-35. doi: 10.1161/01.cir.86.5.1529. PMID: 1423966.
Copy Download .nbib Format: NLM
A prospective study of dehydroepiandrosterone sulfate, mortality, and cardiovascular disease.

The New England journal of medicine

Barrett-Connor E, Khaw KT, Yen SS.
PMID: 2946952
N Engl J Med. 1986 Dec 11;315(24):1519-24. doi: 10.1056/NEJM198612113152405.

It has been postulated that dehydroepiandrosterone (DHEA) and its sulfate ester, dehydroepiandrosterone sulfate (DHEAS), the major secretory products of the human adrenal gland, may be discriminators of life expectancy and aging. We examined the relation of base-line circulating DHEAS...

Cite
Barrett-Connor E, Khaw KT, Yen SS. A prospective study of dehydroepiandrosterone sulfate, mortality, and cardiovascular disease. N Engl J Med. 1986;315(24):1519-24doi: 10.1056/NEJM198612113152405.
Barrett-Connor, E., Khaw, K. T., & Yen, S. S. (1986). A prospective study of dehydroepiandrosterone sulfate, mortality, and cardiovascular disease. The New England journal of medicine, 315(24), 1519-24. https://doi.org/10.1056/NEJM198612113152405
Barrett-Connor, E, et al. "A prospective study of dehydroepiandrosterone sulfate, mortality, and cardiovascular disease." The New England journal of medicine vol. 315,24 (1986): 1519-24. doi: https://doi.org/10.1056/NEJM198612113152405
Barrett-Connor E, Khaw KT, Yen SS. A prospective study of dehydroepiandrosterone sulfate, mortality, and cardiovascular disease. N Engl J Med. 1986 Dec 11;315(24):1519-24. doi: 10.1056/NEJM198612113152405. PMID: 2946952.
Copy Download .nbib Format: NLM
The effect of phenytoin and carbamazepine on serum dehydroepiandrosterone sulfate in men and women who have partial seizures with temporal lobe involvement.

The Journal of clinical endocrinology and metabolism

Levesque LA, Herzog AG, Seibel MM.
PMID: 2940256
J Clin Endocrinol Metab. 1986 Jul;63(1):243-5. doi: 10.1210/jcem-63-1-243.

In a study of 16 men and 55 women with temporal lobe epilepsy (TLE), we found that the serum dehydroepiandrosterone sulfate (DHEA-S) level was significantly lower (P less than 0.05) in patients who were treated with phenytoin (mean +/-...

Cite
Levesque LA, Herzog AG, Seibel MM. The effect of phenytoin and carbamazepine on serum dehydroepiandrosterone sulfate in men and women who have partial seizures with temporal lobe involvement. J Clin Endocrinol Metab. 1986;63(1):243-5doi: 10.1210/jcem-63-1-243.
Levesque, L. A., Herzog, A. G., & Seibel, M. M. (1986). The effect of phenytoin and carbamazepine on serum dehydroepiandrosterone sulfate in men and women who have partial seizures with temporal lobe involvement. The Journal of clinical endocrinology and metabolism, 63(1), 243-5. https://doi.org/10.1210/jcem-63-1-243
Levesque, L A, et al. "The effect of phenytoin and carbamazepine on serum dehydroepiandrosterone sulfate in men and women who have partial seizures with temporal lobe involvement." The Journal of clinical endocrinology and metabolism vol. 63,1 (1986): 243-5. doi: https://doi.org/10.1210/jcem-63-1-243
Levesque LA, Herzog AG, Seibel MM. The effect of phenytoin and carbamazepine on serum dehydroepiandrosterone sulfate in men and women who have partial seizures with temporal lobe involvement. J Clin Endocrinol Metab. 1986 Jul;63(1):243-5. doi: 10.1210/jcem-63-1-243. PMID: 2940256.
Copy Download .nbib Format: NLM
Do DHEA/DHEAS play a protective role in coronary heart disease?.

Physiological research

Porsová-Dutoit I, Sulcová J, Stárka L.
PMID: 10984071
Physiol Res. 2000;49:S43-56.

Dehydroepiandrosterone (DHEA) and dehydroepiandrosterone-sulfate (DHEAS), the major androgens secreted by human adrenal glands, were suggested to play a protective role in the pathogenesis of atherosclerosis and coronary heart disease. On the basis of a critical review of all existing...

Cite
Porsová-Dutoit I, Sulcová J, Stárka L. Do DHEA/DHEAS play a protective role in coronary heart disease?. Physiol Res. 2000;49:S43-56
Porsová-Dutoit, I., Sulcová, J., & Stárka, L. (2000). Do DHEA/DHEAS play a protective role in coronary heart disease?. Physiological research, 49S43-56.
Porsová-Dutoit, I, et al. "Do DHEA/DHEAS play a protective role in coronary heart disease?." Physiological research vol. 49 (2000): S43-56.
Porsová-Dutoit I, Sulcová J, Stárka L. Do DHEA/DHEAS play a protective role in coronary heart disease?. Physiol Res. 2000;49:S43-56. PMID: 10984071.
Copy Download .nbib Format: NLM
Lack of effect of exercise training on dehydroepiandrosterone-sulfate.

The American journal of the medical sciences

Milani RV, Lavie CJ, Barbee RW, Littman AB.
PMID: 7503104
Am J Med Sci. 1995 Dec;310(6):242-6.

Although functions of dehydroepiandrosterone (DHEA) and its sulfate ester are unknown, investigators have found an inverse relation between DHEA-sulfate levels and coronary artery disease, suggesting its importance as an inverse coronary risk factor. In previous studies, where behavioral therapy...

Cite
Milani RV, Lavie CJ, Barbee RW, et al. Lack of effect of exercise training on dehydroepiandrosterone-sulfate. Am J Med Sci. 1995;310(6):242-6
Milani, R. V., Lavie, C. J., Barbee, R. W., & Littman, A. B. (1995). Lack of effect of exercise training on dehydroepiandrosterone-sulfate. The American journal of the medical sciences, 310(6), 242-6.
Milani, R V, et al. "Lack of effect of exercise training on dehydroepiandrosterone-sulfate." The American journal of the medical sciences vol. 310,6 (1995): 242-6.
Milani RV, Lavie CJ, Barbee RW, Littman AB. Lack of effect of exercise training on dehydroepiandrosterone-sulfate. Am J Med Sci. 1995 Dec;310(6):242-6. PMID: 7503104.
Copy Download .nbib Format: NLM
Dehydroepiandrosterone (DHEA), DHEA sulfate, and aging: contribution of the DHEAge Study to a sociobiomedical issue.

Proceedings of the National Academy of Sciences of the United States of America

Baulieu EE, Thomas G, Legrain S, Lahlou N, Roger M, Debuire B, Faucounau V, Girard L, Hervy MP, Latour F, Leaud MC, Mokrane A, Pitti-Ferrandi H, Trivalle C, de Lacharrière O, Nouveau S, Rakoto-Arison B, Souberbielle JC, Raison J, Le Bouc Y, Raynaud A, Girerd X, Forette F.
PMID: 10760294
Proc Natl Acad Sci U S A. 2000 Apr 11;97(8):4279-84. doi: 10.1073/pnas.97.8.4279.

The secretion and the blood levels of the adrenal steroid dehydroepiandrosterone (DHEA) and its sulfate ester (DHEAS) decrease profoundly with age, and the question is posed whether administration of the steroid to compensate for the decline counteracts defects associated...

Cite
Baulieu EE, Thomas G, Legrain S, et al. Dehydroepiandrosterone (DHEA), DHEA sulfate, and aging: contribution of the DHEAge Study to a sociobiomedical issue. Proc Natl Acad Sci U S A. 2000;97(8):4279-84doi: 10.1073/pnas.97.8.4279.
Baulieu, E. E., Thomas, G., Legrain, S., Lahlou, N., Roger, M., Debuire, B., Faucounau, V., Girard, L., Hervy, M. P., Latour, F., Leaud, M. C., Mokrane, A., Pitti-Ferrandi, H., Trivalle, C., de Lacharrière, O., Nouveau, S., Rakoto-Arison, B., Souberbielle, J. C., Raison, J., Le Bouc, Y., Raynaud, A., Girerd, X., & Forette, F. (2000). Dehydroepiandrosterone (DHEA), DHEA sulfate, and aging: contribution of the DHEAge Study to a sociobiomedical issue. Proceedings of the National Academy of Sciences of the United States of America, 97(8), 4279-84. https://doi.org/10.1073/pnas.97.8.4279
Baulieu, E E, et al. "Dehydroepiandrosterone (DHEA), DHEA sulfate, and aging: contribution of the DHEAge Study to a sociobiomedical issue." Proceedings of the National Academy of Sciences of the United States of America vol. 97,8 (2000): 4279-84. doi: https://doi.org/10.1073/pnas.97.8.4279
Baulieu EE, Thomas G, Legrain S, Lahlou N, Roger M, Debuire B, Faucounau V, Girard L, Hervy MP, Latour F, Leaud MC, Mokrane A, Pitti-Ferrandi H, Trivalle C, de Lacharrière O, Nouveau S, Rakoto-Arison B, Souberbielle JC, Raison J, Le Bouc Y, Raynaud A, Girerd X, Forette F. Dehydroepiandrosterone (DHEA), DHEA sulfate, and aging: contribution of the DHEAge Study to a sociobiomedical issue. Proc Natl Acad Sci U S A. 2000 Apr 11;97(8):4279-84. doi: 10.1073/pnas.97.8.4279. PMID: 10760294; PMCID: PMC18228.
Copy Download .nbib Format: NLM
[Dehydroepiandrosterone therapy in men with angiographically verified coronary heart disease: the effects on plasminogen activator inhibitor-1 (PAI-1), tissue plasminogen activator (tPA) and fibrinogen plasma concentrations].

Endokrynologia Polska

Rabijewski M, Zgliczyński W.
PMID: 17940987
Endokrynol Pol. 2007 May-Jun;58(3):213-9.

INTRODUCTION: The aim of this study was to analyze the influence of DHEA therapy on fibrinogen, plasminogen activator inhibitor-1 (PAI-1) and tissue plasminogen activator (tPA) plasma concentrations in men with decreased serum DHEA-S levels and angiographically verified coronary heart...

Cite
Rabijewski M, Zgliczyński W. Stosowanie DHEA u mezczyzn z koronograficznie potwierdzona choroba wieńcowa: wpływ na stezenia inhibitora aktywatora plazminogenu (PAI-1), tkankowego aktywatora plazminogenu (tPA) oraz fibrynogenu. [Dehydroepiandrosterone therapy in men with angiographically verified coronary heart disease: the effects on plasminogen activator inhibitor-1 (PAI-1), tissue plasminogen activator (tPA) and fibrinogen plasma concentrations]. Endokrynol Pol. 2007;58(3):213-9
Rabijewski, M., & Zgliczyński, W. (2007). Stosowanie DHEA u mezczyzn z koronograficznie potwierdzona choroba wieńcowa: wpływ na stezenia inhibitora aktywatora plazminogenu (PAI-1), tkankowego aktywatora plazminogenu (tPA) oraz fibrynogenu. [Dehydroepiandrosterone therapy in men with angiographically verified coronary heart disease: the effects on plasminogen activator inhibitor-1 (PAI-1), tissue plasminogen activator (tPA) and fibrinogen plasma concentrations]. Endokrynologia Polska, 58(3), 213-9.
Rabijewski, Michał, and Zgliczyński, Wojciech. "Stosowanie DHEA u mezczyzn z koronograficznie potwierdzona choroba wieńcowa: wpływ na stezenia inhibitora aktywatora plazminogenu (PAI-1), tkankowego aktywatora plazminogenu (tPA) oraz fibrynogenu." [Dehydroepiandrosterone therapy in men with angiographically verified coronary heart disease: the effects on plasminogen activator inhibitor-1 (PAI-1), tissue plasminogen activator (tPA) and fibrinogen plasma concentrations]. Endokrynologia Polska vol. 58,3 (2007): 213-9.
Rabijewski M, Zgliczyński W. Stosowanie DHEA u mezczyzn z koronograficznie potwierdzona choroba wieńcowa: wpływ na stezenia inhibitora aktywatora plazminogenu (PAI-1), tkankowego aktywatora plazminogenu (tPA) oraz fibrynogenu. [Dehydroepiandrosterone therapy in men with angiographically verified coronary heart disease: the effects on plasminogen activator inhibitor-1 (PAI-1), tissue plasminogen activator (tPA) and fibrinogen plasma concentrations]. Endokrynol Pol. 2007 May-Jun;58(3):213-9. Polish. PMID: 17940987.
Copy Download .nbib Format: NLM
Decreased dehydroepiandrosterone (DHEA) and dehydroepiandrosterone sulfate (DHEAS) concentrations in plasma of Alzheimer's disease (AD) patients.

Archives of gerontology and geriatrics

Aldred S, Mecocci P.
PMID: 19665809
Arch Gerontol Geriatr. 2010 Jul-Aug;51(1):e16-8. doi: 10.1016/j.archger.2009.07.001. Epub 2009 Aug 08.

DHEA is secreted by the adrenal cortex and is also a neurosteroid. Its sulfate (DHEAS) is the most abundant steroid in circulation. The levels of both are seen to decline in concentration with age. Evidence is available for altered...

Cite
Aldred S, Mecocci P. Decreased dehydroepiandrosterone (DHEA) and dehydroepiandrosterone sulfate (DHEAS) concentrations in plasma of Alzheimer's disease (AD) patients. Arch Gerontol Geriatr. 2009;51(1):e16-8doi: 10.1016/j.archger.2009.07.001.
Aldred, S., & Mecocci, P. (2010). Decreased dehydroepiandrosterone (DHEA) and dehydroepiandrosterone sulfate (DHEAS) concentrations in plasma of Alzheimer's disease (AD) patients. Archives of gerontology and geriatrics, 51(1), e16-8. https://doi.org/10.1016/j.archger.2009.07.001
Aldred, Sarah, and Mecocci, Patrizia. "Decreased dehydroepiandrosterone (DHEA) and dehydroepiandrosterone sulfate (DHEAS) concentrations in plasma of Alzheimer's disease (AD) patients." Archives of gerontology and geriatrics vol. 51,1 (2010): e16-8. doi: https://doi.org/10.1016/j.archger.2009.07.001
Aldred S, Mecocci P. Decreased dehydroepiandrosterone (DHEA) and dehydroepiandrosterone sulfate (DHEAS) concentrations in plasma of Alzheimer's disease (AD) patients. Arch Gerontol Geriatr. 2010 Jul-Aug;51(1):e16-8. doi: 10.1016/j.archger.2009.07.001. Epub 2009 Aug 08. PMID: 19665809.
Copy Download .nbib Format: NLM
Wide distribution of the serum dehydroepiandrosterone and sex steroid levels in postmenopausal women: role of the ovary?.

Menopause (New York, N.Y.)

Labrie F, Martel C, Balser J.
PMID: 20683211
Menopause. 2011 Jan;18(1):30-43. doi: 10.1097/gme.0b013e3181e195a6.

OBJECTIVE: Because the exclusive source of sex steroids (at least estrogens) after menopause is recognized to be dehydroepiandrosterone (DHEA), this study examines the interindividual variability of serum DHEA and its metabolites as well as the contribution of the ovary...

Cite
Labrie F, Martel C, Balser J. Wide distribution of the serum dehydroepiandrosterone and sex steroid levels in postmenopausal women: role of the ovary?. Menopause. 2011;18(1):30-43doi: 10.1097/gme.0b013e3181e195a6.
Labrie, F., Martel, C., & Balser, J. (2011). Wide distribution of the serum dehydroepiandrosterone and sex steroid levels in postmenopausal women: role of the ovary?. Menopause (New York, N.Y.), 18(1), 30-43. https://doi.org/10.1097/gme.0b013e3181e195a6
Labrie, Fernand, et al. "Wide distribution of the serum dehydroepiandrosterone and sex steroid levels in postmenopausal women: role of the ovary?." Menopause (New York, N.Y.) vol. 18,1 (2011): 30-43. doi: https://doi.org/10.1097/gme.0b013e3181e195a6
Labrie F, Martel C, Balser J. Wide distribution of the serum dehydroepiandrosterone and sex steroid levels in postmenopausal women: role of the ovary?. Menopause. 2011 Jan;18(1):30-43. doi: 10.1097/gme.0b013e3181e195a6. PMID: 20683211.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 112 entries